Upgrading of Gleason score and prostate volume: A clinicopathological analysis

BJU International

Volumn 111, Issue 8, 2013, Pages 1310-1316

  Kim, Kwang Hyun ^a   Lim, Sey Kiat ^a   Shin, Tae Young ^a   Lee, Joo Yong ^a   Chung, Byung Ha ^a   Rha, Koon Ho ^a   Hong, Sung Joon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

neoplasm grading; prostatectomy (Mesh); prostatic neoplasm; tumour burden

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84878318574     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2013.11799.x     Document Type: Article

References (24)

1. Cohen MS, Hanley RS, Kurteva T, et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol 2008; 54: 371-381
2. Boorjian SA, Karnes RJ, Crispen PL, et al. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol 2009; 181: 95-104
3. Davies JD, Aghazadeh MA, Phillips S, et al. Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol 2011; 186: 2221-2227
4. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349: 215-224 (Pubitemid 36859473)
5. Kulkarni GS, Al Azab R, Lockwood G, et al. Evidence for a biopsy derived grade artifact among larger prostate glands. J Urol 2006; 175: 505-509 (Pubitemid 43067339)
6. Dong F, Jones JS, Stephenson AJ, Magi Galluzzi C, Reuther AM, Klein EA,. Prostate cancer volume at biopsy predicts clinically significant upgrading. J Urol 2008; 179: 896-900
7. Turley RS, Hamilton RJ, Terris MK, et al. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol 2008; 179: 523-527
8. Epstein JI, Feng Z, Trock BJ, Pierorazio PM,. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 2012; 61: 1019-1024
9. Freedland SJ, Isaacs WB, Platz EA, et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 2005; 23: 7546-7554 (Pubitemid 46291818)
10. Briganti A, Chun FK, Suardi N, et al. Prostate volume and adverse prostate cancer features: fact not artifact. Eur J Cancer 2007; 43: 2669-2677 (Pubitemid 350151846)
11. Newton MR, Phillips S, Chang S, et al. Smaller prostate size predicts high grade prostate cancer at final pathology. J Urol 2010; 184: 930-937
12. Humphrey PA,. Tumor amount in prostatic tissues in relation to patient outcome and management. Am J Clin Pathol 2009; 131: 7-10
13. Epstein JI,. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 2011; 186: 790-797
14. Watanabe H, Igari D, Tanahashi Y, Harada K, Saito M,. Measurements of size and weight of prostate by means of transrectal ultrasonotomography. Tohoku J Exp Med 1974; 114: 277-285
15. Albertsen PC, Hanley JA, Fine J,. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005 293: 2095-2101 (Pubitemid 40617061)
16. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998 280: 969-974 (Pubitemid 28445094)
17. Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS,. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. BJU Int 2009; 103: 43-48
18. Pierorazio PM, Kinnaman MD, Wosnitzer MS, Benson MC, McKiernan JM, Goluboff ET,. Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy. Urology 2007; 70: 696-701 (Pubitemid 350030218)
19. Turley RS, Terris MK, Kane CJ, et al. The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database. BJU Int 2008; 102: 1074-1079
20. Kassouf W, Nakanishi H, Ochiai A, Babaian KN, Troncoso P, Babaian RJ,. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies. J Urol 2007; 178: 111-114 (Pubitemid 46898463)
21. Imamoto T, Suzuki H, Utsumi T, et al. External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients. Urology 2010; 76: 404-410
22. Hong SK, Han BK, Lee ST, et al. Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (> or = 12)-core prostate biopsy. World J Urol 2009; 27: 271-276
23. Song C, Ro JY, Lee M, et al. Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 2006; 68: 820-824 (Pubitemid 44633367)
24. Man A, Pickles T, Chi KN,. Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J Urol 2003; 170: 901-904 (Pubitemid 36999586)